当前位置: X-MOL 学术Lancet Respir. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Perplexing mortality data from triple therapy trials in COPD - Author's reply.
The Lancet Respiratory Medicine ( IF 38.7 ) Pub Date : 2021-08-19 , DOI: 10.1016/s2213-2600(21)00330-1
Fernando J Martinez 1 , Patrick Darken 2 , Paul Dorinsky 3 ,
Affiliation  



中文翻译:

来自慢性阻塞性肺病三联疗法试验的令人费解的死亡率数据——作者的答复。

更新日期:2021-08-19
down
wechat
bug